Veterans Prostate Cancer Awareness

CategoriesIn the News

U.S. FDA Approves Additional Indication of NUBEQA® (darolutamide) in Combination with Docetaxel for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

WHIPPANY, N.J.–(BUSINESS WIRE)– Bayer announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the oral androgen receptor inhibitor (ARi) NUBEQA® (darolutamide) with docetaxel for the treatment of adult patients with metastatic hormone-sensitive prostate cancer (mHSPC).

CategoriesIn the News

Aviator Cancer Bill Would Push VA to Study Toxins Air Crews Faced, Assess Links to Cancers

Just like the fighter pilots they supported, many troops who fueled, armed, and maintained warplanes have suffered from cancer or seen their former colleagues diagnosed with the disease. There’s no data yet on how many ground crew members have gotten sick, but a new bill introduced Thursday would require the Department of Veterans Affairs to identify the cancer incidence in the entire aviation community, as well as what toxins they faced, and whether there could be a link to their illnesses.